Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes [Phase 1, Phase 2]
This clinical trial update provides safety and pharmacokinetic data for CBX129801 in patients with Type 1 diabetes, reported across Phase 1 …
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy [Phase 2]
This is a Phase 2 randomized, double-blind trial evaluating ABT-639 for diabetic peripheral neuropathy to assess its effect on pain-related …
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy [Phase 2]
A completed Phase 2 safety study evaluating intranasal insulin for diabetic peripheral neuropathy in individuals with Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy
The document reports a completed administrative claims analysis of Metanx for diabetic peripheral neuropathy. It provides status details of …
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Fall Risk Assessment in People With Diabetic Neuropathy
A completed clinical trial evaluating fall risk assessment in individuals with Diabetic Peripheral Neuropathy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy [Phase 3]
A Phase 3 randomized trial compared tapentadol extended-release with placebo in adults with chronic painful diabetic peripheral neuropathy; …
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) [Phase 3]
A Phase 3 trial comparing Actovegin with placebo in symptomatic diabetic peripheral neuropathy has been completed.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating TAK-128 for diabetic peripheral neuropathy has completed, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 safety study of TAK-128 in subjects with diabetic peripheral neuropathy has been terminated; no specific results are provided in t…
-
CLINICAL_TRIALS research · 2012-01-11Clinical Trial Update: Metanx® P.L.U.S. Program (Progress Through Learning, Understanding & Support)
Update on the Metanx PLUS Program clinical trial for diabetic peripheral neuropathy; current status is unknown.
-
FDA approval · 2011-06-20FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of gabapentin for diabetic peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy. [Phase 2]
A long-term safety study of S,S-Reboxetine in chronic painful diabetic peripheral neuropathy was terminated in Phase 2.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 study evaluating the efficacy and safety of amitriptyline/ketamine topical cream in diabetic peripheral neuropathy and neuralgia; re…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN) [Phase 2]
Phase 2 study evaluating gabapentin enacarbil for neuropathic pain in diabetic peripheral neuropathy; results posted in 2011.
-
FDA approval · 2011-04-26FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin submitted by Mylan Pharmaceuticals Inc., updating the regulatory status of the produc…
-
CLINICAL_TRIALS research · 2011-04-13Clinical Trial Update: Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy [NA]
This document reports a preliminary assessment of the VascuActive device's efficacy for diabetic peripheral neuropathy. The trial status and…
-
FDA approval · 2011-04-12FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]
A long-term Phase 3 study evaluating safety and efficacy of pregabalin for pain associated with diabetic peripheral neuropathy has completed…
-
FDA approval · 2010-11-01FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental NDA for tapentadol hydrochloride by Hikma Pharmaceuticals USA Inc., allowing a generic version of tapentadol to …
-
CLINICAL_TRIALS trial_result · 2010-05-31Clinical Trial Update: Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating safety and efficacy of AEG33773 versus placebo in patients with painful diabetic peripheral neuropathy has complete…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy [Phase 3]
Phase 3 safety and efficacy study of tapentadol extended-release for painful diabetic peripheral neuropathy has completed and posted results…
-
FDA approval · 2010-01-04FDA Approved: PREGABALIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for pregabalin from Mylan Pharmaceuticals, confirming a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain [Phase 3]
Phase 3 trial update evaluating the efficacy of nabilone for diabetic peripheral neuropathy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 4]
Phase 4 trial evaluating whether duloxetine maintains its pain-relieving effect in patients with diabetic peripheral neuropathy. Results wer…